Stockreport

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

ProSomnus, Inc.  (OSA) 
PDF PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), [Read more]